Delayed Hypersensitivity Reaction to Leucovorin. 2019

Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
Ohio University College of Osteopathic Medicine, Athens, OH.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D012811 Sigmoid Neoplasms Tumors or cancer of the SIGMOID COLON. Cancer of Sigmoid,Sigmoid Cancer,Cancer of the Sigmoid,Neoplasms, Sigmoid,Sigmoid Colon Cancer,Sigmoid Colon Neoplasms,Sigmoidal Cancer,Cancer, Sigmoid,Cancer, Sigmoid Colon,Colon Cancer, Sigmoid,Colon Neoplasms, Sigmoid,Neoplasm, Sigmoid,Neoplasm, Sigmoid Colon,Neoplasms, Sigmoid Colon,Sigmoid Colon Neoplasm,Sigmoid Neoplasm

Related Publications

Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
March 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
January 1997, Pharmacotherapy,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
November 1993, The British journal of dermatology,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
September 1970, The Tohoku journal of experimental medicine,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
January 2018, Movement disorders clinical practice,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
November 1991, The Australian and New Zealand journal of surgery,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
February 1996, Allergy,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
November 2006, Annals of oncology : official journal of the European Society for Medical Oncology,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
November 1996, Allergy,
Vishnu Gudimetla, and Jad Daw, and Farah Almhana, and Abdo Haddad
June 2024, International journal of dermatology,
Copied contents to your clipboard!